Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels
11 января 2021 года
05:46
Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels
Текст новости:
Title: Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels
Author, co-author: SIBILLE, Anne; HENKET, Monique; Corhay, Jean-Louis; Louis, Renaud; DUYSINX, Bernard
Abstract: [No abstract available]


Текст со страницы (автоматическое получение):
Document type :
Discipline(s) :
To cite this reference:
Title :
Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels
Language :
Автоматическая система мониторинга и отбора информации
Источник
Другие материалы рубрики
  10 января 2021 года
05:45
CA19.9 assays provide clinically different results for the patients